Viewing Study NCT06247332


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2025-12-25 @ 7:10 PM
Study NCT ID: NCT06247332
Status: COMPLETED
Last Update Posted: 2025-02-18
First Post: 2024-01-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SENSING-AI in Patients With Long COVID (SENSING-AI)
Sponsor: Adhera Health, Inc.
Organization:

Study Overview

Official Title: Retrospective Data Collection for SENSING-AI: a Wearable Platform for the Early Diagnosis of Emotional Disorders and Exacerbations in Patients With Long COVID Through the Use of Artificial Intelligence
Status: COMPLETED
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SENSING-AI
Brief Summary: The retrospective study will be used to develop an artificial intelligence model of risk stratification of physiological and psychological complications arising from the information available in the electronic medical record and first consultation report to support patients and healthcare professionals in better managing the healthcare process for patients diagnosed with long COVID.
Detailed Description: The stratification of the risk of complications related to persistent COVID both physiological and psychological in a personalized way would optimize the cost-effectiveness model for the management of these patients. Similarly, the early detection of complications associated with persistent COVID in patients belonging to vulnerable groups would improve care times and, therefore, the patient's prognosis.

The primary objective for this study is to gather anonymized retrospective data of patients suffering from long COVID in order to contribute to the generation of the SENSING-AI cohort.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: